Gut Bacteria and Colorectal Cancer: New Insights from Research
Scientists have made notable progress in deciphering the role of gut bacteria, particularly a newly identified virus, in contributing to colorectal cancer, which ranks as one of the most prevalent forms of cancer in developed nations.
This research, conducted by teams from Denmark and Australia, aimed to deepen the understanding of the previously noted connection between colorectal cancer and a specific bacterium named Bacteroides fragilis.
Interestingly, this bacterium can also be present in healthy individuals. Therefore, the researchers sought to determine if there were significant differences in the bacterium’s characteristics in those who develop cancer—and they indeed found some compelling evidence.
Microbiologist Flemming Damgaard from Odense University Hospital remarked on the puzzling nature of finding the same bacterium associated with colorectal cancer while it also inhabits the guts of healthy people. The team stumbled upon a previously unidentified virus that seems closely related to bacteria found in colorectal cancer patients.
Through genetic sequencing methods, they examined the gut flora of cancer patients within a large study in Denmark. It was observed that in patients with cancer, B. fragilis frequently had a bacteriophage attached. These bacteriophages are viruses that infect bacteria, using them to replicate and spread.
While the initial findings were based on a smaller group of individuals, they were later validated with broader data from 877 people, both with and without colorectal cancer. This suggested that the viruses in B. fragilis might influence the likelihood of developing cancer.
The data revealed that those diagnosed with colorectal cancer were twice as likely to exhibit detectable levels of the bacteriophage in their gut. Moreover, this particular virus doesn’t match any previously recorded types.
However, researchers caution against jumping to conclusions regarding direct causation. The association they’ve found is promising and may aid in further investigations into colorectal cancer and its potential treatments, though there could be underlying factors still at play.
Damgaard highlighted that the focus shouldn’t solely be on the bacterium itself, but rather on its interaction with the accompanying virus. It’s still unclear whether the virus contributes to cancer directly, or if it merely indicates that some other changes within the gut are occurring.
About 80% of the risk tied to colorectal cancer is linked to environmental influences, including the composition of gut bacteria. Thus, understanding how these factors interrelate could significantly impact cancer cases globally.
That said, studying gut bacteria is quite complex. These intricate microbiomes serve as both reflections of bodily states and active influencers affecting everything from sleep quality to weight management.
Interestingly, there’s an added layer for future research to explore: not just bacteria, but the viruses inhabiting them. One intriguing question arises about the ways B. fragilis may interact with its bacteriophage companions.
Even though the research is still in its early stages, any progress towards understanding how cancer begins is crucial for developing targeted therapies, although that may require time.
The researchers also propose that their findings might facilitate colorectal cancer screening. With additional studies, it may be possible to develop stool sample analyses to detect this B. fragilis virus.
In the words of Damgaard, “The diversity and number of bacteria in the gut is vast. Previously, it felt like searching for a needle in a haystack. Now, we’re examining whether something inside the bacteria—namely viruses—could clarify the differences.”
He added that in the near term, they can investigate whether the virus can help identify individuals at heightened risk.
This research has been documented in Communications Medicine.
